Skip to main content
logo
Lexaria Bioscience Corp. (LEXX)
NASDAQ: LEXX · Real-Time Price · USD
1.080
+0.020 (1.89%)
Nov 25, 2025, 4:00 PM EST - Market closed

Revenue by Product

Millions USD. Fiscal year is Sep - Aug.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Aug '24 Aug '23 Aug '22 Aug '21 Aug '20 2015 - 2019
Intellectual Property Licensing
457.99K
Log In
Log In
Log In
Log In
Upgrade
Intellectual Property Licensing Growth
211.98%
Log In
Log In
Log In
Log In
Upgrade
Business-to-business Product
5.39K
Log In
Log In
Log In
Log In
Upgrade
Business-to-business Product Growth
-87.80%
Log In
Log In
Log In
Log In
Upgrade
Research & Development
900.00
Log In
Log In
Log In
Log In
Upgrade
Research & Development Growth
-97.45%
Log In
Log In
Log In
Log In
Upgrade
Corporate
-
Log In
Log In
Log In
Log In
Upgrade
Corporate Growth
-
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Millions USD. Fiscal year is Sep - Aug.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Aug '24 Aug '23 Aug '22 Aug '21 Aug '20 2015 - 2019
United States and Canada
464.28K
Log In
Log In
Log In
Log In
Upgrade
United States and Canada Growth
105.24%
Log In
Log In
Log In
Log In
Upgrade